Futura Medical schedules AGM for June 19, 2025

Published 27/05/2025, 07:26
Futura Medical schedules AGM for June 19, 2025

LONDON - Futura Medical (TASE:BLWV) plc (AIM:FUM), a consumer healthcare company known for developing sexual health products like Eroxon, has announced that its Annual General Meeting (AGM) will be held on Thursday, June 19, 2025. The meeting is set to take place at the offices of Panmure Liberum in London, as per the company’s recent statement.

Shareholders intending to attend the AGM are required to register by 10:00 am on June 16, 2025. Those unable to attend can cast their proxy votes online, use the CREST electronic proxy appointment service, or for institutional investors, the Proxymity platform. Proxy votes must be logged by 10:00 am on June 17, 2025. For those not present, the company will provide arrangements to listen to the proceedings remotely, although remote listeners will not have the opportunity to vote or interact during the meeting.

In addition, the company’s annual report for the year ending December 31, 2024, is now available on Futura Medical’s website. This report includes comprehensive accounts and the Notice of AGM, accessible to shareholders in line with the Companies Act 2006.

Futura Medical is recognized for its focus on research, development, and commercialization of topical gel formulations, primarily in the sexual health sector. Eroxon, the company’s flagship product for treating Erectile Dysfunction (ED), is the only topical gel treatment for ED available over the counter, with a quick action time of ten minutes. The product has received industry awards and holds distribution partnerships with major markets, including Haleon in the US and Cooper Consumer Health in Europe.

The company’s press release statement provides all the details regarding the upcoming AGM and the availability of the annual report. Shareholders and interested parties are encouraged to review the documents provided for complete information on the company’s performance and future plans.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.